Abstract
The present invention relates to biomarkers of lung cancer, particularly to markers that enable distinguishing between subtypes of non-small cell lung cancer (NSCLC), particularly between adenocarcinoma (AC) and squamous cell carcinoma (SCC). In particular, the present invention relates to means and methods for diagnosing, assessing the level of severity and selecting methods of treating NSCLC.
| Original language | English |
|---|---|
| Patent number | US2020173998 |
| IPC | G01N 33/ 68 A I |
| Priority date | 22/05/18 |
| State | Published - 4 Jun 2020 |
